Maximiliano Omazabal

Title: Maximiliano Omazabal: Innovator in Vaccine Development

Introduction

Maximiliano Omazabal is a notable inventor based in Bell, Buenos Aires, Argentina. He has made significant contributions to the field of vaccine development, particularly in the prevention of infections. His innovative work has led to the creation of a vaccine that utilizes outer membrane vesicles (OMVs) and various adjuvants to enhance immune response.

Latest Patents

Omazabal holds 1 patent for a vaccine designed to prevent infections. This vaccine comprises at least outer membrane vesicles (OMVs) and includes excipients and/or adjuvants. The formulation may contain adjuvants such as aluminum hydroxide and immunogens like tetanus toxoid and diphtheria toxoid. The vaccine is designed to deliver between 3 to 20 µg per dose of OMVs and a specific amount of lipopolysaccharide per dose.

Career Highlights

Throughout his career, Omazabal has worked with esteemed institutions such as the National Scientific and Technical Research Council (CONICET) and the National University of La Plata. His research has focused on developing effective vaccines that can provide cross-activity against various pathogens.

Collaborations

Omazabal has collaborated with notable colleagues, including Daniela Hozbor and Daniela Bottero. Their joint efforts have contributed to advancements in vaccine research and development.

Conclusion

Maximiliano Omazabal's work in vaccine innovation highlights his commitment to improving public health through scientific research. His contributions are paving the way for more effective preventive measures against infections.